AMS - Cardiovascular Emergencies, Part 4: Tachycardias; Chest Pain; Cases – ACS; STEMI & NSTE-ACS: Literature Review (USB Flash Drive)

AMS - Cardiovascular Emergencies, Part 4: Tachycardias; Chest Pain; Cases – ACS; STEMI & NSTE-ACS: Literature Review (USB Flash Drive)

$189.00


Topics and Objectives

Title: CARDIOVASCULAR EMERGENCIES, PART IV: TACHYCARDIAS; CHEST PAIN; Cases – ACS; STEMI & NSTE-ACS: Literature Review

Faculty: Amal Mattu, M.D., F.A.A.E.M., F.A.C.E.P.

Original Release Date: April 1, 2019  Expiration Date: July 1, 2021

TOPIC 1: Wide-Complex Tachycardias: Myths and Pitfalls.

Upon completion of this session, the participant should be able to: COMP

  1. Identify difficulties in distinguishing amongst various types of wide complex tachycardias.
  2. Describe pitfalls in the diagnosis and treatment of WPW-related tachydysrhythmia.
  3. List the shortcomings associated with the use of amiodarone in managing patients with wide complex tachycardias.

TOPIC 2: Low-Risk Chest Pain: A 2018 Approach.

Upon completion of this session, the participant should be able to: COMP

  1. Describe some common pearls and pitfalls that occur in the diagnosis of ACS.
  2. Review the most common accelerated diagnostic protocols for evaluating patients with suspected ACS.
  3. Describe a rational approach to the modern day evaluation of low risk chest pain

TOPIC 3: Updates “Remember That Patient You Saw Last Night?” Case Reviews in Missed ACS. 

Upon completion of this session, the participant should be able to: COMP

  1. List high risk groups that are associated with missed ACS.
  2. Discuss the shortcomings of stress testing and cardiac catheterization.
  3. Discuss the limitations of current troponin testing.

TOPIC 4: STEMI and NSTE-ACS: Recent Literature Updates.

Upon completion of this session, the participant should be able to: COMP

  1. List newer ECG criteria that warrant acute reperfusion therapy.
  2. Describe the newest diagnostic strategies for ACS.
  3. Describe the updated treatment protocols ACS

Total Cost: $

    Title: CARDIOVASCULAR EMERGENCIES, PART IV: TACHYCARDIAS; CHEST PAIN; Cases – ACS; STEMI & NSTE-ACS: Literature Review

    Faculty: Amal Mattu, M.D., F.A.A.E.M., F.A.C.E.P.

    Original Release Date: April 1, 2019  Expiration Date: July 1, 2021

    TOPIC 1: Wide-Complex Tachycardias: Myths and Pitfalls.

    Upon completion of this session, the participant should be able to: COMP

    1. Identify difficulties in distinguishing amongst various types of wide complex tachycardias.
    2. Describe pitfalls in the diagnosis and treatment of WPW-related tachydysrhythmia.
    3. List the shortcomings associated with the use of amiodarone in managing patients with wide complex tachycardias.

    TOPIC 2: Low-Risk Chest Pain: A 2018 Approach.

    Upon completion of this session, the participant should be able to: COMP

    1. Describe some common pearls and pitfalls that occur in the diagnosis of ACS.
    2. Review the most common accelerated diagnostic protocols for evaluating patients with suspected ACS.
    3. Describe a rational approach to the modern day evaluation of low risk chest pain

    TOPIC 3: Updates “Remember That Patient You Saw Last Night?” Case Reviews in Missed ACS. 

    Upon completion of this session, the participant should be able to: COMP

    1. List high risk groups that are associated with missed ACS.
    2. Discuss the shortcomings of stress testing and cardiac catheterization.
    3. Discuss the limitations of current troponin testing.

    TOPIC 4: STEMI and NSTE-ACS: Recent Literature Updates.

    Upon completion of this session, the participant should be able to: COMP

    1. List newer ECG criteria that warrant acute reperfusion therapy.
    2. Describe the newest diagnostic strategies for ACS.
    3. Describe the updated treatment protocols ACS
    When you add a gift card to your CME purchase from American Medical Seminars:
    • The receipt for any incentive-associated purchase will designate the value of the gift card separately from the cost of the learning activity.
    • This incentive may have implications on your tax reporting obligations. Any reimbursed amount must be declared as personal income for tax purposes.